(Q44793035)

6 December 2017

title

Addition of the alpha2-antagonist yohimbine to fluoxetine: effects on rate of antidepressant response (English)

1 reference

6 December 2017

1 reference

Ralitza Gueorguieva

7

0 references

author name string

Gerard Sanacora

1

1 reference

6 December 2017

Robert M Berman

2

1 reference

6 December 2017

Angela Cappiello

3

1 reference

6 December 2017

Dan A Oren

4

1 reference

6 December 2017

Akira Kugaya

5

1 reference

6 December 2017

Nianjun Liu

6

1 reference

6 December 2017

Donna Fasula

8

1 reference

6 December 2017

Dennis S Charney

9

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

6 December 2017

published in

Neuropsychopharmacology

1 reference

6 December 2017

volume

29

1 reference

6 December 2017

issue

6

1 reference

6 December 2017

page(s)

1166-1171

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300418

6 December 2017

exact match

0 references

cites work

A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300418

Yohimbine augmentation of fluvoxamine in refractory depression: a single-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300418

Desipramine-yohimbine combination treatment of refractory depression. Implications for the beta-adrenergic receptor hypothesis of antidepressant action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300418

Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300418

Idazoxan (RX 781094) selectively antagonizes α2-adrenoceptors on rat central neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300418

Noradrenergic modulation of serotonin release in rat dorsal and median raphé nuclei via alpha(1) and alpha(2A) adrenoceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300418

Dose-response relationship for oral idazoxan effects in healthy human subjects: comparison with oral yohimbine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300418

Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake-associated female sexual dysfunction: a randomized, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300418

In vivo electrophysiological evidence for tonic activation by endogenous noradrenaline of alpha 2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300418

Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300418

Involvement of alpha-receptors in clonidine-induced inhibition of transmitter release from central monoamine neurones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300418

Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300418

Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300418

Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300418

7 January 2021

Endogenous noradrenaline activates alpha 2-adrenoceptors on serotonergic nerve endings in human and rat neocortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300418

7 January 2021

Noradrenaline inhibits depolarization-induced 3H-serotonin release from slices of rat hippocampus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300418

7 January 2021

Reliability and validity of the symptoms of major depressive illness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300418

7 January 2021

The Arizona Sexual Experience Scale (ASEX): reliability and validity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300418

7 January 2021

Does mirtazapine have a more rapid onset than SSRIs?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300418

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300418

1 reference

6 December 2017

1 reference